Aeterna Zentaris: Q3 Earnings Snapshot
By AP News
Published - Nov 09, 2023, 08:36 AM ET
Last Updated - Nov 09, 2023, 08:39 AM EST
TORONTO (AP) — TORONTO (AP) — Aeterna Zentaris Inc. (AEZS) on Thursday reported a loss of $4.1 million in its third quarter.
The Toronto-based company said it had a loss of 85 cents per share.
The drug developer posted revenue of $3,000 in the period.
The company's shares closed at $1.50. A year ago, they were trading at $3.81.
